# Naver

> Naver is a VC fund in Seongnam backing Software and Artificial Intelligence. See 127 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Seongnam, South Korea
- Total investments: 127
- Last investment: Jun 2026
- Lead investor: 41%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/naver
- X (Twitter): https://twitter.com/naver_diary
- Website: http://www.navercorp.com
- Facebook: https://www.facebook.com/navercorp

Naver is a VC fund in Seongnam focused on Software and Artificial Intelligence. Naver operates as a search engine and e-commerce platform providing fintech, digital content, and cloud services.The company introduces innovative search services such as ‘Comprehensive Search,’ ‘Knowledge iN,’ and ‘Real-time Rising Keyword.' It also offers UGC services such as Blog and Cafe; Junior Naver, a children’s portal; Happybean, anonline donation portal. NAVER launched its Webtoon service in June 2004 and has pioneered the distribution and consumption of webtoons, also known as digital comics. In addition, NAVER also offers services for the global market, including the mobile messenger LINE through LINE Corporation, NAVER’s subsidiary; the video messenger Snow; and the group communication service BAND.NAVER is also involved in software development and distribution; performances and exhibitions business; mobile content development and distribution; search advertising; internet commerce and customer service business; the operation and security services of IT infrastructure; operating online shopping services, and mobile applications marketing.Lee Hae-Jin and Lee Joon-ho headquartered the company in Seongnam, Kyonggi-do, South Korea in 1999.

## Contacts

5 contacts available for Naver. Shizune tracks 12 team members at Naver. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/naver-corporation?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $4k–$20M |
| Series A | $2M–$20M |
| Series B | $1.7M–$65M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 21 | 17% |
| Artificial Intelligence | 18 | 14% |
| E-Commerce | 16 | 13% |
| Apps | 13 | 10% |
| Information Technology | 13 | 10% |

165 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 26 | 20% |
| Series A | 22 | 17% |
| Series B | 21 | 17% |
| Series C | 15 | 12% |
| Funding Round | 10 | 8% |

12 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 67 | 53% |
| United States | 13 | 10% |
| Indonesia | 4 | 3% |
| India | 2 | 2% |
| Japan | 2 | 2% |

14 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Choi Soo-yeon | CEO | 1 | https://shizune.co/investors/profile/choi-soo-yeon |
| Hae-Jin Lee | GIO and Co-Founder | 0 | https://shizune.co/investors/profile/lee-hae-jin |
| Ian Kwon | Business Development | 0 | https://shizune.co/investors/profile/ian-kwon |
| Jeong-an Lee | Leader of Investment and Development | 1 | https://shizune.co/investors/profile/jeong-an-lee |
| Joon-ho Lee | Co-founder | 0 | https://shizune.co/investors/profile/joon-ho-lee |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PROMEDIUS | Promedius is a MedTech startup, based in Seoul, Korea, focusing on optimizing radiologists workflow of medical imaging interpretation to drive improved patient outcomes. Our platform, AIdant, is providing an AI-enabled medical imaging cloud solution for individual doctors, medical institutions, and teleradiology centers. We believe ourcomprehensive zero-footprint AI solution can cover the geographic issues, after-hour issues, and lack of the radiologists issue in the diagnostic imaging market. | $14M | Series B | Jun 05, 2026 |  |
| UVify | UVify is designer and manufacturer of swarm drones and autonomous drones for research, industrial, and drone light shows. |  | Corporate Round | Jun 01, 2026 |  |
| TR | TR is a digital healthcare company that designs and develops medical devices and electronic products. |  | Corporate Round | May 15, 2026 |  |
| Market Kurly | Market Kurly is an online premium grocery service that compares quality and price when looking for good ingredients for foreign goodies.Market Kurly is a food delivery and logistics platform that enables users to order food via the website and receive it the following morning. The company delivers fresh high-end desserts, bread, milk, bottledwater, condiments such as flour & salt, processed foods, and more.The company was founded in 2015 and based in Seoul, South Korea. | $22.8M | Corporate Round | May 06, 2026 |  |
| Medical AI | Medical AI is a medical and diagnostic laboratory company that specializes in AI-ECG Software as a Medical Device, detecting heart failure and myocardial infarction with cutting-edge technology. It features advanced capabilities that allow for the early detection of functional and structural heart diseases, such as heart failure, which traditionalelectrocardiogram (ECG) measurements may not reveal. ECG testing is recognized as a non-invasive and universal approach to evaluating heart function. Furthermore, the company has developed 'AiTiALVSD-1L,' a medical device software that aids in diagnosing heart failure using electrocardiograms obtained from wearable devices like the Galaxy Watch, achieving the distinction of being the first in the world to receive regulatory approval. This product, created in partnership with Samsung Electronics, is broadening the application of medical and healthcare AI from clinical settings, such as hospitals, into everyday life. |  | Corporate Round | Feb 04, 2026 |  |
| Humanscape | Humanscape is a rare disease health-tech company working to bring better chances of cure for patients. By collecting comprehensive patient health data from genotype, clinical to phenotype data and systematically compiling it into a complete, ready-to-use data set, pharmaceuticals and researchers can significantly reduce both time and cost for newdrug development. | $3.4M | Series C | Dec 14, 2025 |  |
| Note | Note develops a media platform that aims to help creators publish sentences, images, and audio over the Internet. The company's platform enables users to receive updates in order to keep track of daily information, allowing creators and readers to feel comfortable creating things and delivering them pleasantly to the recipients. | $13M | Corporate Round | Nov 05, 2025 |  |
| EverEx | EverEx is a software-based therapeutics company specialized on musculoskeletal disorders with an AI-enabled pose estimation. | $2.8M | Series B | Nov 05, 2025 |  |
| JNPMEDI | JNPMEDI is a Clinical Trial Platforms company that offers services as a Clinical Research Organization (CRO), investment assistance, and licensing consulting. It also delivers clinical data management and operational services that adhere to international standards via its proprietary platform. The organization provides capabilities for clinicaldata management, operations, clinical trials, and quality control, all grounded in international standards through its unique platform. |  | Series B | Aug 13, 2025 |  |
| Deskera | Deskera Cloud ERP is a fully integrated Cloud ERP Suite designed to run your business on the cloud. Its solutions allow SMEs to track finances, manage customers, and hire and manage employees.Its modules include Enterprise Resource Planning (ERP), Customer Relationship Management (CRM), Manufacture Resource Planning (MRP), Project Management (PM)and Human Capital Management (HCM). The application is a complete business suite that has all the features you will ever need to run your business. Deskera was founded in 2008 and is based in San Jose, California with offices in Singapore, Malaysia, Indonesia, and India. |  | Series B | Jul 16, 2024 |  |

10 of 127 investments shown.

## Co-investors
- [IMM Investment](https://shizune.co/investors/profile/imm-investment) — VC Fund, 6 deals together
- [Line](https://shizune.co/investors/profile/line-corporation) — VC Fund, 6 deals together
- [Mirae Asset Venture Investment](https://shizune.co/investors/profile/mirae-asset-venture-investment) — VC Fund, 6 deals together
- [Korea Development Bank](https://shizune.co/investors/profile/korean-development-bank) — VC Fund, 5 deals together
- [Mirae Asset Capital](https://shizune.co/investors/profile/mirae-asset-capital) — VC Fund, 5 deals together
- [Atinum Partners](https://shizune.co/investors/profile/atinum-investment) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [All Investors in South Korea](https://shizune.co/investors/investors-south-korea)
- [All VC Funds in South Korea](https://shizune.co/investors/vc-funds-south-korea)
- [SaaS Investors in South Korea](https://shizune.co/investors/saas-investors-south-korea)
- [SaaS VC Funds in South Korea](https://shizune.co/investors/saas-vc-funds-south-korea)
- [Enterprise Investors in South Korea](https://shizune.co/investors/enterprise-investors-south-korea)
- [Enterprise VC Funds in South Korea](https://shizune.co/investors/enterprise-vc-funds-south-korea)

## FAQ

### What does Naver invest in?

Naver invests primarily in Software, Artificial Intelligence and E-Commerce startups, most often at Seed and Series A stage. Most of the 127 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Naver's check size?

Naver typically joins rounds of $4k–$20M at Seed, $2M–$20M at Series A and $1.7M–$65M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Naver participates in.

### How do I contact Naver?

Public channels for Naver include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Naver?

The team at Naver includes Choi Soo-yeon (CEO), Hae-Jin Lee (GIO and Co-Founder) and Ian Kwon (Business Development), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co